Exemplis Discimus 2008, 152(2):181-189

Fusce vel nulla interdum est rutrum sodales.

Obdulla Yavoka, Drex Staddb, Giran Sa-Vinb, Goror Gregorya, Bree Ettea, Megara Golladioa, Genna Vel Aatha
a 2nd Clinic of Medical Ethics, Tatooine University Hospital, Cato Neimoidia Republic
b Centre of Operation Room Technology, Teaching Hospital of Byss, Republic of Naboo

BACKGROUND: Maecenas pellentesque libero sit amet leo aliquet imperdiet. Pellentesque metus felis, dictum quis, luctus in, semper id, risus. Pellentesque vitae elit non diam tempor rutrum. Pellentesque purus nisl, sodales non, accumsan sit amet, aliquam id, dolor. Vestibulum nunc nunc, interdum eget, facilisis non, ullamcorper ut, nibh. Vestibulum nec ligula sit amet tortor porta feugiat. Pellentesque eget velit sed ante euismod iaculis. Suspendisse nisi risus, tempor id, gravida nec, volutpat nec, dui.

METHODS AND RESULTS: Mauris quis velit nec massa convallis eleifend. Duis sit amet nisl at felis convallis dictum. Donec eros augue, posuere et, aliquam sed, tristique et, leo. Suspendisse id leo nec nunc pulvinar suscipit. Duis sit amet nisl at felis convallis dictum. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Vivamus vitae leo vel urna molestie placerat. Cras eget lacus vel ante adipiscing posuere..

CONCLUSIONS: Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec ut elit sed mauris luctus ullamcorper. Donec nibh pede, adipiscing vitae, pulvinar ut, aliquam dapibus, enim. Maecenas nec erat sed risus accumsan faucibus.. Curabitur a lorem vitae erat adipiscing feugiat. Nam eros lacus, fermentum vel, tristique vel, cursus sit amet, felis. Maecenas et purus vitae mauris facilisis aliquet. Aliquam leo felis, tincidunt at, fringilla tempor, eleifend quis, ligula.

Keywords: Praesent ipsum, Sed dui, Praesent nunc, Nulla facilisi, Cras nisl, Cras enim, Maecenas vel nulla, Curabitur a felis

Received: October 21, 2008; Accepted: August 5, 2008; Published: December 1, 2008 

Open full article

References

  1. Murray RK, et al. Harpers Biochemistry, 23. ed, Appleton and Lange, a Publishing Division of Prentice-Hall International, Connecticut, 1993.
  2. Altmann SW, Davis HR, Zhu I, et al. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science 2004; 303:1201-1204. Go to original source... Go to PubMed...
  3. Davis HR, Zhu I, Hoos LM, et al. Niemann-Pick C1 Like 1 (NPCL) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole body cholesterol homeostasis. J. Biol Chem 2004; 279:33486-33592.
  4. Levy E, Schohraya S, Sinnett D, et al. Intestinal cholesterol transport proteins: an update and beyond. Curr Opinion in Lipid 2007; 18:310-318. Go to original source... Go to PubMed...
  5. Bietrix F, Yan D, Nauze M, et al. Accelerated lipid absorption in mice overexpressing intestinal SR-BI J. Biol Chem 2006; 281:7214- 7219. Go to original source... Go to PubMed...
  6. Nauli AM, Nassir F, Zheng, et al. CD 36 is important for chylomicron formation and secretion and may mediate cholesterol uptake in the proximal intestine. Gastroenterology 2006; 131:1197-1207. Go to original source... Go to PubMed...
  7. Kramer W, Girbig F, Corsiero D, et al. Aminopeptidase N (CD13) is a molecular target of the cholesterol absorption inhibitor ezetimibe in the enterocyte brush border membrane. J Biol. Chem 2005; 280:1306-1320. Go to original source...
  8. Repa JJ, Berge KE, Pomajzl C, et al. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG by the liver X receptors alpha and beta. J. Biol Chem 2002; 277:18793-18800. Go to original source... Go to PubMed...
  9. Van der Veen JN, Kruit JK, Havinga R, et al. Reduced cholesterol absorption upon PPAR delta activation coincides with decreased intestinal expression of NPC1L1. J Lipid Res 2005; 46:526-534. Go to original source... Go to PubMed...
  10. Gibbons GF, Mitropoulos KA, Myant NB. Biochemistry of cholesterol. Elsevier Biomedical Press, Amsterdam-New York-Oxford, 1982.
  11. Rawson RB. The SREBP pathway--insights from Insigs and insects. Nat Rev MolCell Biol 2003; 4:631-640. Go to original source... Go to PubMed...
  12. Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver, J. Clin. Invest. 2002; 109:1125-1131. Go to original source...
  13. Acton S, Rigotti A, Landschulz KT, et al. Identifi cation of scavenger receptor SR-BI as a high-density lipoprotein receptor. Science 271:518-520.
  14. Attie AD, Kastelein JP, Hayden MR. Pivotal role of ABCA1 in reverse cholesterol transport infl uencing HDL levels and susceptibility to atherosclerosis. J. Lipid Res. 2001; 42:1717-1726.
  15. Lo Sasso G, Petruzelli M, Moschetta A. A translational view on the biliary lipid secretory network. Biochem Biophys Acta 2008, in press, doi:10.1016/j.bbalip.2007.12.002.
  16. Porter JA, Young KE, Beachy PA . "Cholesterol modifi cation of hedgehog signaling proteins in animal development". Science 274(5285):255-259.
  17. Avigan J, Steinberg D. Sterol and bile acid excretion in man and the eff ects of dietary fat. J. Clin Invest 1965; 44:1845-56. Go to original source... Go to PubMed...
  18. Parker TS, McNamara DJ, Brown CD et al. Plasma mevalonate as a measure of cholesterol synthesis in man. J. Clin. Invest. 1984; 74:795-804. Go to original source... Go to PubMed...
  19. Hy¹pler R, Crhová S, Gaspariè J, et al. Determination of isoprene in human expired breath using solid-phase microextraction and gas chromatography-mass spectrometry. J Chromatogr B Biomed Sci Appl. 2000; 28:183-90. Go to original source...
  20. Miettinen TA. Diurnal variation of cholesterol precursors squalene and methyl sterols in human plasma lipoproteins. J. Lipid Res. 1982; 23:466-473.
  21. Bjorkhem I, Miettinen T, Reihner E, et al. Correlation between serum levels of some cholesterol precursors and activity of HMGCoA reductase in human liver. J. Lipid Res. 1987; 28:1137-43.
  22. Jones PJH. Regulation of cholesterol biosynthesis by diet in humans. Am. J. Clin. Nutr. 1997; 66:438-46.
  23. Taylor CB, Mikkelson B, Anderson JA, et al. Human serum cholesterol synthesis measured with the deuterium label. Arch. Path.1966; 81:213-31.
  24. Jones JP, Pappu AS, Illingworth DR, et al. Correspondence between plasma mevalonic acid levels and deuterium uptake in measuring human cholesterol synthesis. Eur. J. Clin. Invest. 1992; 22:609-20. Go to original source...
  25. Beylot M. Use of stable isotopes to evaluate the functional eff ects of nutrients.Curr Opin Clin Nutr Metab Care. 2006; 9(6):734-9. Go to original source... Go to PubMed...
  26. Kuksis A. Plasma non-cholesterol sterols. Journal of Chromatography A 2001; 935:203-236. Go to original source... Go to PubMed...
  27. Thannhauser SJ, Schaber H. Uber bezie-hungen des gleichgewichtes cholesterin und cholesterinester im blut und serum zur leberfunkton. Klin Wochenschr 1926; 7:252-3. Go to original source...
  28. Alvarez C, Ramos A. Lipids, lipoproteins and apoproteins in serum during infection. Clin Chem 1986; 32:142-5. Go to PubMed...
  29. Coombes EJ, Shakespeare PG, Batstone GF. Lipoprotein changes after burn injury in man. J Trauma 1980; 20:971-5. Go to original source... Go to PubMed...
  30. Budd D, Ginsberg H. Hypocholesterolemia and acute myogenous leukemie: association between disease activity and plasma low density lipoprotein cholesterol concentrations. Cancer 1986; 58:1361-5. Go to original source... Go to PubMed...
  31. Goichot B, Schlienger JL, Grunenberger F, et al. Low cholesterol concentrations in free-living elderly subjects: Relations with dietary intake and nutritional status. Am J Clin Nutr 1995; 62(3):547. Go to PubMed...
  32. Bakalar B, Zadak Z, Pachl J. Severe hypocholesterolemia is associated with adrenal insuffi ciency in multiple trauma patients. Intens Care Med 2001; 27(S2):S253.
  33. Marik PE. Dyslipidemia in the critically ill. Crit Care Clin 2006; 22:151-159. Go to original source... Go to PubMed...
  34. Lopez-Martinez J, Sanchez-Castilla M, Garcia-de-Lorenzo A: Hypocholesterolemia in critically ill patients. Intensive Care Med 2000; 26:259-60. Go to original source... Go to PubMed...
  35. Giovannini I, Boldrini G, Chiarla C, et al. Pathophysiologic correlates of hypocholesterolemia in critically ill surgical patients. Intensive Care Med 1999; 25:748-751. Go to original source... Go to PubMed...
  36. Gordon BR, Parker TS, Levine DM, et al. Low lipid concentrations in critical illness: implications for preventing and treating endotoxemia. Crit Care Med 1996; 24:584-9. Go to original source... Go to PubMed...
  37. Gordon BR, Parker TS, Levine DM, et al. Relationship of hypolipidemia to cytokine concentrations and outcomes in critically ill surgical patients. Crit Care Med. 2001; 29: 1563-8. Go to original source... Go to PubMed...
  38. Akgun S, Ertel NH, Mosenthal A, et al. Postsurgical reduction of serum lipoproteins: Interleukin-6 and the acute-phase response. J Lab Clin Med 1998:131:103-8. Go to original source... Go to PubMed...
  39. Diederich W, Orso E, Dronik W, et al. Apolipoprotein A1 and HDL3 inhibit spreading of primary human monocytes through a mechanism that involves cholesterol depletion and regulation of CDC 42. Atherosclerosis 2001; 159:313-24. Go to original source... Go to PubMed...
  40. Ruan XZ, Varghese Z, Powers SH, et al. Dysregulation of LDL receptor under the infl uence of infl ammatory cytokines: A new pathway for foam cell formation. Kidney Int 2001; 60:2037-38. Go to original source... Go to PubMed...
  41. de Beer FC, Connel PM, Yu J, et al. HDL modifi cation by secreting phospholipase A2 promotes scavenger receptor class B type 1 interaction and accelerates HDL catabolism. J Lipid Res 2000; 41:1849-57. Go to PubMed...
  42. Leonarduzzi G, Arkaw MC, Basaga H, et al. Lipid oxydation products in cell signaling. Free Radic Biol Med 2000; 28:1370-78. Go to original source... Go to PubMed...
  43. Buechler C, Ritter M, Quoc CD,et al. Lipopolysaccharide inhibits the expression of the scavenger receptor Cla-1 in human monocytes and macrophages.Biochem Biophys Commun 1999; 262:251-54. Go to original source... Go to PubMed...
  44. Gierens H, Nauck M, Roth M, et al. Interleukin6 stimulates LDL receptor gene expression via activation of sterol-responsive and Sp1 binding elements. Atheroscler Thromb Vasc Biol 2000; 20:1777-83. Go to original source... Go to PubMed...
  45. Roth G, Kotzka J, Kremer L, et al. MAP kinases Erkl/2 phosphorylate sterol regulatory binding-element protein (SREBP)-1a at serine 117 in vitro. Jbiol Chem 2000; 275:33302-307. Go to original source... Go to PubMed...
  46. van Leeuwen HJ, Heezius EC, Dallinga GM, et al. Lipoprotein metabolism in patients with severe sepsis. Crit Care Med 2003; 31:1359-66. Go to original source... Go to PubMed...
  47. Fraunberger P, Schaefer S, Werdan K, et al. Reduction of circulating cholesterol and apolipoprotein levels during sepsis. Clin Chem Lab Med 1999; 37: 357-62. Go to original source... Go to PubMed...
  48. Mentz MH, Magnette J. Hypocholesterolemia during the acute phase of an infl ammatory reaction of infectious origin.120cases. Rev Med Interne 1998; 19:168-72. Go to PubMed...
  49. Fraunberger P, Pilz G, Cremer P, et al. Association of serum tumor necrosis factor levels with decrease of cholesterol during septic shock. Shock1998; 10:359-63. Go to original source... Go to PubMed...
  50. Dunham CM, Fealk MH, Sever WE. Following severe injury, hypocholesterolemia improves with convalescence but persists with organ failure or onset of infection. Crit Care 2003; 7:R145-53. Go to original source... Go to PubMed...
  51. Ettinger WH, Varma VK, Sorci-Thomas M, et al. Cytokines decrease apolipoprotein accumulation in medium from Hep G2 cells. Arterioscler Thromb 1994; 14:8-13. Go to original source... Go to PubMed...
  52. Spriggs DR, Sherman ML, Michie H. Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion: a phase 1 pharmacologic study. J Natl Cancer Inst 1988; 80:1039-44. Go to original source... Go to PubMed...
  53. van Gameren MM, Willemse PH, Mulder NH. Eff ects of recombinant human interleukin-6 in cancer patients: a phase I-II study. Blood 1994; 84:1434-41. Go to PubMed...
  54. Memon RA, Staprans I, Noor M, et al. Infection and infl ammation induce LDL oxidation in vivo. Arterioscler Thromb Vasc Biol 2000; 20:1536-42. Go to original source... Go to PubMed...
  55. Tietge UJ, Maugeais C, Cain W,et al. Overexpression of secretory phospholipase A2 causes rapid catabolism and altered tissue uptake of high-density lipoprotein cholesterol ester and lipoprotein A-1. J Biol Chem 2000; 275:10077-84. Go to original source... Go to PubMed...
  56. Panousis CG, Zuckerman SH. Interferon-gamma induces downregulation of Tangier disease gene (ATP-binding-cassette transporter- 1) in macrophage-derived foam cells. Arterioscler Thromb Vasc Biol 2000; 20:1567-71. Go to original source... Go to PubMed...
  57. Feingold KR, Soued M, Adi S, et al. Tumor necrosis factor increased hepatic very-low-density lipoprotein production and increased serum triglyceride levels in diabetic rats. Diabetes 1990; 39:1569-74. Go to original source... Go to PubMed...
  58. Feingold KR, Serio MK, Adi S, et al. Tumor necrosis factor stimulates hepatic lipid synthesis and secretion. Endocrinology 1989; 124:2336-42. Go to original source... Go to PubMed...
  59. Robin AP, Askanazi J, Greenwood MR, et al. Lipoprotein lipase activity in surgical patients: infl uence of trauma and infection. Surgery 1981; 90:401-8. Go to PubMed...
  60. Beutler B, Mahoney J, Le TN, et al. Purifi cation of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells. J Exp Med 1985; 161:984-95. Go to original source... Go to PubMed...
  61. Bonville DA, Parker TS, Levine DM, et al. The relationship of hypocholesterolemia to cytokine concentrations and mortality in critically ill patients with systemic infl ammatory response syndrome. Surg Infect 2004; 5:39-49. Go to original source... Go to PubMed...
  62. Freudenberg MA, Bog-Hansen TC, Back U. Interaction of lipopolysaccharides with plasma high-density lipoprotein in rats. Infect Immun 1980; 28:373-380. Go to PubMed...
  63. Levine DM, Parker TS, Donelly TM, et al. In vivo protection against endotoxin by plasma high density lipoprotein. Proc Natl Acad Sci USA 1993; 90:12040-12044. Go to original source...
  64. Ulevitch RJ, Johnson AR, Weinstein DB. New function for high density lipoproteins. Isolation and characterization of a bacterial lipopolysaccharide high-density lipoprotein complex formed in rabbit plasma. J Clin Invest. 1981; 67(3):827-37. Go to original source... Go to PubMed...
  65. Harris HW, Grunfed C, Feingold KR, et al. Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J Clin Invest 1993; 91:1028-34. Go to original source... Go to PubMed...
  66. Parker TS, Levine DM, Chang JC, et al. Reconstituted high-density lipoprotein neutralizes gram-negative bacterial lipopolysaccharides in human whole blood. Infect Immun 1995; 63:253-58. Go to PubMed...
  67. Casas AT, Hubsch AP, Rogers BC, et al. Reconstituted high-density lipoprotein reduces LPS-stimulated TNF alpha. J Surg Res 1995; 59:544-552. Go to original source... Go to PubMed...
  68. Hubsch AP, Powell FS, Lerch PG, et al. A reconstituted, apolipoprotein A-1 containing lipoprotein reduces tumor necrosis factor release and attenuated shock in endotoxemic rabbits. Circ Shock 1993; 40:14-23. Go to PubMed...
  69. Hubsch AP, Casas AT,Doran JE. Protective eff ects of reconstituted high-density lipoprotein in rabbit gram-negative bacteremia models. J Lab Clin Med 1995; 126:548-558. Go to PubMed...
  70. Casas AT, Hubsch AP, Doran JE. Eff ects of reconstituted high-density lipoprotein in persistent gram-negative bacteremia. Am Surg 1996; 62:350-355. Go to PubMed...
  71. Goldfarb RD, Parker TS, Levine DM, et al. Protein-free phospholipid emulsion treatment improved cardiopulmonary function and survival in porcine sepsis. Am J Physiol Regul Integr Comp Physiol 2003; 284:R550-R557. Go to original source... Go to PubMed...
  72. Malyszko J, Urano T, Knofl er R, et al. Relationships between serum lipids, serotonin, platelet aggregation and some fi brinolytic parameters in humans. Life Sci 1994; 55:1619-23. Go to original source... Go to PubMed...
  73. Koller R, Koller F, Binder BR. Purifi cation and identifi cation of the lipoprotein-binding proteins from human blood platelet membrane. J Biol Chem 1989; 264:12412-418. Go to PubMed...
  74. Pajkrt D, Lerch PG, van der PT, et al. Diff erential eff ects of reconstituted high-density lipoprotein on coagulation, fi brinolysis and platelet activation during human endotoxemia. Thromb Haemost 1997; 77:303-7. Go to PubMed...
  75. Barie PS, Hydo LJ, Fischer E. Comparison of APACHE II and III scoring systems for mortality prediction in critical surgical illness. Arch Surg 1995; 130:77-82. Go to original source... Go to PubMed...
  76. Sankaran RT, Mattana J, Pollack S, et al. Laboratory abnormalities in patients with bacterial pneumonia. Chest 1997; 111:595-600. Go to original source... Go to PubMed...
  77. Leardi S, Altilia F, Delmonaco S, et al. Blood levels of cholesterol and postoperative septic complications. A. Chir Ital 2000; 71:233- 237.
  78. Iribarren C, Jacobs DR, Sidney S, et al. Cohort study of serum total cholesterol and in- hospital incidence of infections diseases. Epidemiol Infect 1998; 121:335-47. Go to original source... Go to PubMed...
  79. Muldoon MF, Marsland A, Flory JD, et al. Immune system diff erences in men with hypo- or hypercholesterolemia. Clin Immunol Immunopathol 1997; 84:145-149. Go to original source... Go to PubMed...
  80. Chenaud C, Merlani PG, Roux-Lombard P, et al. Low apolipoprotein A-I level at intensive care unit admission and systemic infl ammatory response syndrome exacerbation. Crit Care Med 2004; 32:632-637. Go to original source... Go to PubMed...
  81. Chernow B. Variables aff ecting outcome in critically ill patients. Chest 1999; 115:71S-76S. Go to original source... Go to PubMed...
  82. Chiarla C, Giovannini I, Siegel JH, et al. Relationship of plasma cholesterol to doses of branch-chain amino acids in sepsis. Crit Care Med 1990; 18:32-36. Go to original source... Go to PubMed...
  83. Chiarla C, Giovannini I, Siegel JH, et al. Relationship of plasma acute-phase protein to amino acid levels during high-dose branched chain amino acid support in sepsis. In: Faist E, Meakins JL, Schildberg FW editors. Host Defense Dysfunction in Trauma, Shock and Sepsis. Berlin Heidelberg New York: Springer; 1993; 1030-1034.
  84. Chiarla C, Giovannini I, Siegel JH, et al. The relationship between plasma taurine and other amino acid levels in human sepsis. J Nutr 2000; 130:2222-2227. Go to PubMed...
  85. Druml W. Is cholesterol a conditionally essential nutrient in critically ill patients. Wien Klin Wochenschr 2003; 115/21-22:740-742. Go to original source... Go to PubMed...
  86. Fraunberger P, Nagel D, Walli AK, et al. Serum cholesterol and mortality in patients with multiple organ failure. Crit Care Med 2000; 28:3574-3575. Go to original source... Go to PubMed...
  87. Windler E, Ewers-Grabow U, Thiery J, et al. The prognostic value of hypocholesterolemia in hospitalized patients. Clin Invest 1994; 72:939-43. Go to original source... Go to PubMed...
  88. Marik PE. Adrenal insufficiency: the link between low Apolipiprotein A-1 levels and poor outcome in the critically ill? Crit Care Med 2004; 32:1977-8. Go to original source... Go to PubMed...
  89. Marik PE, Zaloga GP. Adrenal insuffi ciency in the critically ill: a new look at an old problem. Chest 2002; 122:1784-96. Go to original source... Go to PubMed...
  90. Marik PE, Zaloga GP. Adrenal insuffi ciency during septic shock. Crit Care Med 2003; 31:141-5. Go to original source... Go to PubMed...
  91. Borkowski AJ, Levin S, Delcroix C, et al. Blood cholesterol and hydrocortisone production in man: quantitative aspects of the utilization of circulating cholesterol by the adrenals at rest and under adrenocortocotropin stimulation. Clin Invest 1967; 46:797-811. Go to original source... Go to PubMed...
  92. Yaguchi H, Tsutsumi K, Shimono K, et al. Involvement of high-density lipoprotein as substrate cholesterol for steroidogenesis by bovine adrenal fasciculo-reticularis cells. Life Sci 1998; 62:1387-95. Go to original source... Go to PubMed...
  93. Roux C, Wolf C, Mulliez N, et al. Role of cholesterol in embryonic development. Am J Clin Nutr 2000; 71(S):1270S-1279S.
  94. Chiarla C, Giovannini I, Siegel JH. The relationship between plasma cholesterol, amino acids and acute phase proteins in sepsis. Amino Acids 2004; 27(1):97-100. Go to original source... Go to PubMed...
  95. Giovannini I, Chiarla C, Giuliante F, et al. The relationship between albumin, other plasma proteins and variables, and age in the acute phase response after liver resection in man. Amino Acids 2006; 31:463-469. Go to original source... Go to PubMed...
  96. Giovannini I, Chiarla C, Greco F, Boldrini G, Nuzzo G. Characterization of Biochemical and Clinical Correlates of Hypocholesterolemia after Hepatectomy. Clin Chem; 2003; 49(2):317-319.
  97. Blanco-Colio LM, Tunon J, Martin-Ventura JL, et al. Anti-infl ammatory and immunomodulatory eff ects of statins. KidneyInt 2003; 63:12-23.
  98. Merx MW, Liehn EA, Janssens U et al. HMG-Co-A reductase inhibitor simvastatin profoundly improves survival in a murine model sepsis. Circulation 2004; 109:2560-65. Go to original source... Go to PubMed...
  99. Almong Y, Shefer A, Novack V, et al. Prior statin therapy is associated with a decreased rate of severe sepsis. Circulation 2004; 110:880-85. Go to original source... Go to PubMed...

Return to the content